NCT03824327View on ClinicalTrials.gov

Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 7, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
Lung Non-Small Cell Carcinoma
Interventions
PROCEDURE

Blood Oxygen Level Dependent Imaging

Undergo BOLD fMRI

DRUG

Papaverine Hydrochloride

Given IV

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

Trial Locations (1)

43210

RECRUITING

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER